Lv1
20 积分 2022-09-02 加入
Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis
4个月前
已完结
Real world analysis on the determinants of survival in primary plasma cell leukemia in the United States
4个月前
已完结
Non-small-cell lung cancer
4个月前
已完结
Systemic Light Chain Amyloidosis
4个月前
已完结
[Expression and Significance of PD-1, PD-L1 and CTLA-4 in the Bone Marrow of Patients with Multiple Myeloma]
5个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
7个月前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
8个月前
已完结
皖公网安备34019202002308
